Aldeyra Therapeutics, Inc. (ALDX)
ALDX Stock Chart More Charts
ALDX Price/Volume Stats
| Current price | $8.65 |
| Prev. close | $8.73 |
| Day low | $8.65 |
| Day high | $8.95 |
| 50-day MA | $7.81 |
| 200-day MA | $6.94 |
| 52-week high | $11.90 |
| 52-week low | $3.90 |
| Volume | 99,157 |
| Avg. volume | 98,122 |
| Dividend yield | N/A |
| Market Cap | 173.95M |
ALDX Returns
| 1-mo | 20.14% |
| 3-mo | 13.82% |
| 6-mo | 35.16% |
| 1-year | 82.11% |
| 3-year | 25.91% |
| 5-year | N/A |
| YTD | 27.21% |
| 2017 | 27.10% |
| 2016 | -21.09% |
| 2015 | -6.09% |
| 2014 | N/A |
| 2013 | N/A |
Aldeyra Therapeutics, Inc. (ALDX) Company Bio
Aldeyra Therapeutics, Inc., a biotechnology company, focuses on the development of products for diseases caused by inflammation and inborn errors of metabolism in the United States and internationally. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was founded in 2004 and is based in Lexington, Massachusetts.
Loading social stream, please wait...